VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 218 filers reported holding VERACYTE INC in Q4 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,717,755 | +0.6% | 3,211,630 | +14.8% | 0.02% | +4.3% |
| Q2 2023 | $71,278,287 | +39.2% | 2,798,465 | +21.9% | 0.02% | +35.3% |
| Q1 2023 | $51,199,187 | +163637.8% | 2,296,135 | +74.3% | 0.02% | +88.9% |
| Q4 2022 | $31,269 | -99.8% | 1,317,648 | +63.3% | 0.01% | +80.0% |
| Q3 2022 | $13,397,000 | +1413.8% | 807,066 | +1717.1% | 0.01% | – |
| Q2 2022 | $885,000 | +186.4% | 44,415 | +296.5% | 0.00% | – |
| Q1 2022 | $309,000 | -34.1% | 11,202 | -1.5% | 0.00% | – |
| Q4 2021 | $469,000 | -73.6% | 11,377 | -70.3% | 0.00% | -100.0% |
| Q3 2021 | $1,778,000 | -32.2% | 38,274 | -41.6% | 0.00% | 0.0% |
| Q2 2021 | $2,621,000 | -79.4% | 65,531 | -72.3% | 0.00% | -75.0% |
| Q1 2021 | $12,728,000 | +151.2% | 236,994 | +129.0% | 0.00% | +100.0% |
| Q4 2020 | $5,066,000 | +395.2% | 103,471 | +228.8% | 0.00% | – |
| Q3 2020 | $1,023,000 | – | 31,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |